Perioperative management of the thyrotoxic patient

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 2, 2003, Pages 519-534

  Langley, Roy W ^a,b   Burch, Henry B ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CARBIMAZOLE; CORTICOSTEROID; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; ELECTROLYTE; ESMOLOL; GLUCOSE; GUANETHIDINE; HYDROCORTISONE; HYPERTENSIVE AGENT; IODINE; IOPANOIC ACID; LITHIUM CARBONATE; LUGOL; METOPROLOL; PARACETAMOL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RESERPINE; THIAMAZOLE; THIONAMIDE; THYROID HORMONE; VITAMIN;

AGRANULOCYTOSIS; ARTHRALGIA; CARDIOVASCULAR SYSTEM; DOSE RESPONSE; DRUG ACTIVITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG PROTEIN BINDING; FEVER; GRAVES DISEASE; HOMEOSTASIS; HUMAN; LETHALITY; LIVER TOXICITY; MORBIDITY; PERIOPERATIVE PERIOD; PLASMAPHERESIS; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; SURGICAL MORTALITY; SYMPTOM; THYROID CRISIS; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS; THYROIDECTOMY; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT PLANNING; URTICARIA;

EID: 0038320289     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00010-0     Document Type: Review

References (59)

1. Cady B. History of thyroid and parathyroid surgery. In Cady C, Rossi RL, editors. Surgery of the Thyroid and Parathyroid Glands. 3rd edition. Philadelphia: WB Saunders; 1991. p. 1-4.
2. Parry CH. Collections from the unpublished medical writings of the late Caleb Hillier Parry. London: Underwoods; 1825. volume 2. p. 111-28.
3. Graves RJ. Clinical lectures delivered during the sessions 1834-5 and 1836-7. In: Dunglison's American Medical Library. Philadelphia: Adam Waldie; 1838. p. 134-6.
4. Basedow CA. Exoptahlmos durch hypertrophie des zellgewbes in der augenhohle. Wochenschr Heilkd 1840;6:197, 200.
5. Alsanea O, Clark OH. Treatment of Graves' disease: the advantages of surgery. Endocrinol Metab Clin N Am 2000;29:321-37.
6. Mayo CH, Mayo CW. Pre-iodine and post-iodine days: a review of 37,228 cases of goiter at the Mayo Clinic. Western J Surg 1935;9:477-820.
7. Lee TC, Coffey RJ, Currier BM, Ma XP, Canary JJ. Propranolol and thyroidectomy in the treatment of thyrotoxicosis. Ann Surg 1982;195:766-73.
8. Plummer HS. Results of administering iodine to patients having exophthalmic goiter. JAMA 1923;80:155-6.
9. Lahey FH. The decisions for surgery and the management of the patient with hypertension. Surg Clin N Am 1933;13:731-4.
10. Astwood EB. Treatment of hyperthyroidism with thiourea and thiouracil. JAMA 1943; 122:78-81.
11. Black JW, Crowther AF, Shanks RG, et al. New adrenergic beta-receptor antagonist. Lancet 1964;I:1080-1.
12. Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 1983;4: 378-88.
13. Eriksson M, Rubenfeld S, Garber AJ, Kohler PO. Propranolol does not prevent thyroid storm. N Engl J Med 1977;296:263-4.
14. Tominaga T, Yokoyama N, Nagataki S, et al. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China. Thyroid 1997;7:217-20.
15. Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.
16. Silva JE. Catecholamines and the sympathoadrenal system in thyrotoxicosis. In: Braverman LE, editor. Werner's & Ingbar's The Thyroid. 8th edition. Philadelphia: Lipincott, Williams & Wilkins; 2000. p. 642-51.
17. Okamoto T, Iihara M, Obara T. Management of hyperthyroidism due to Graves' and nodular diseases. World J Surg 2000;24:957-61.
18. Burch HB, Shakir F, Shriver C, Jacques D. Diagnosis and management of the autonomously-functioning thyroid nodule: the Walter Reed Army Medical Center experience 1975-1997. Thyroid 1998;8:871-80.
19. Iudica-Souza C, Burch HB. Amiodarone-induced thyroid dysfunction. The Endocrinologist 1999;9:216-27.
20. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am 1993;22:263-77.
21. Wartofsky L, Ransil BJ, Ingbar SH. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 1970;49:78-86.
22. Wolff J, Chaikoff IL, Goldberg RC, Meier JR. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology 1949;45:504-13.
23. Kutzin H, Modler C, Buschsieweke U. Iodine kinetics in facultative hyperthyroidism. J Mol Med 1980;4:75.
24. Vagenakis AF, Braverman LE. Adverse effects of iodides on thyroid function. Med Clin N Am 1975;59:1075-88.
25. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, editor. Werner's & Ingbar's The Thyroid, 8th edition. Philadelphia: Lipincott; Williams & Wilkins; 2000. p. 691-715.
26. Yeung SC, Go R, Balasubramanyam A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 1995;5:403-5.
27. Friend DG. Iodide therapy and the importance of quantitating the dose. N Engl J Med 1960;263:1358-60.
28. Nabil N, Miner DJ, Amatruda JM. Methimazole: an alternative route of administration. J Clin Endocrinol Metab 1982;54:180-1.
29. Geffner DL, Azukizawa M, Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest 1975;55:224-9.
30. Wool MS. Hyperthyroidism. In: Cady C, Rossi RL, editors. Surgery of the thyroid and parathyroid glands. 3rd edition. Philadelphia: WB Saunders; 1991. p. 121-30.
31. Burman KD, Cooper DS. Evaluation and management of hyperthyroidism. In: Cooper DS, editor. Medical management of thyroid disease. New York: Marcel Dekker Inc.; 2001. p. 33-92.
32. Shanks RG, Hadden DR, Lowe DC, McDevitt DG, Montgomery DA. Controlled trial of propranolol in thyrotoxicosis. Lancet 1969;1:993-4.
33. Gerst PH, Fildes J, Baylor P, Zonszein J. Long-acting beta-adrenergic antagonists as preparation for surgery in thyrotoxicosis. Arch Surg 1986;121:838-40.
34. Thorne AC, Bedford RF. Esmolol for perioperative management of thyrotoxic goiter. Anesthesiology 1989;71:291-4.
35. Vijayakumar HR, Thomas WO, Ferrara JJ. Peri-operative management of severe thyrotoxicosis with esmolol. Anaesthesia 1989;44:406-8.
36. Harrison TS, Siegel JH, Wilson WS, Weber WJ. Adrenergic reactivity in hyperthyroidism. Arch Surg 1967;94:396-402.
37. Coulombe P, Dussault JH, Walker P. Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 1977;44:1185-9.
38. Ratge D, Hansel-Bessey S, Wisser H. Altered plasma catecholamines and numbers of alpha- and beta-adrenergic receptors in platelets and leucocytes in hyperthyroid patients normalized under antithyroid treatment. Acta Endocrinol (Copenh) 1985; 110:75-82.
39. Samaras K, Marel GM. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis. Clin Endocrinol (Oxf) 1996;45:365-8.
40. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70:1518-24.
41. Toft AD, Irvine WJ, McIntosh D, et al. Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy. J Clin Endocrinol Metab 1976;43:1312-6.
42. Cooper DS, Daniels GH, Ladenson PW, Ridgway EC. Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 1982;73:867-71.
43. Lee KS, Kim K, Hur KB, Kim CK. The role of propranolol in the preoperative preparation of patients with Graves' disease. Surg Gynecol Obstet 1986;162:365-9.
44. Lee TC, Coffey RJ, Mackin J, Cobb M, Routon J, Canary JJ. The use of propranolol in the surgical treatment of thyrotoxic patients. Ann Surg 1973;177:643-7.
45. Lennquist S, Jortso E, Anderberg B, Smeds S. Betablockers compared with antithyroid drugs as preoperative treatment in hyperthyroidism: drug tolerance, complications, and postoperative thyroid function. Surgery 1985;98:1141-7.
46. Feely J, Stevenson IH, Crooks J. Increased clearance of propranolol in thyrotoxicosis. Ann Intern Med 1981;94:472-4.
47. Adlerberth A, Stenstrom G, Hasselgren PO. The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study. Ann Surg 1987;205:182-8.
48. Braga M, Cooper DS. Oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab 2001;86:1853-60.
49. Wu SY, Chopra IJ, Solomon DH, Bennett LR. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 1978;46:691-7.
50. Lazarus JH, Richards AR, Addison GM, Owen GM. Treatment of thyrotoxicosis with lithium carbonate. Lancet 1974 Nov 16;2(7890):1160-3.
51. Klein I, Levey GS. The cardiovascular system in thyrotoxicosis. In: Braverman LE, editor. Werner's & Ingbar's the thyroid. 8th edition. Philadelphia: Lipincott Williams & Wilkins; 2000. p. 596-604.
52. Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN. Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 1985;72:45-7.
53. Bartels EC. Use of thiouracil in the preoperative preparation of patients with severe hyperthyroidism. Ann Int Med 1945;22:365-72.
54. Zonszein J, Santangelo RP, Mackin JF, Lee TC, Coffey RJ, Canary JJ. Propranolol therapy in thyrotoxicosis. A review of 84 patients undergoing surgery. Am J Med 1979; 66:411-6.
55. Coyle PJ, Mitchell JE. Thyroidectomy: is Lugol's iodine necessary? Ann R Coll Surg Engl 1982;64:334-5.
56. Chang DC, Wheeler MH, Woodcock JP, et al. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery 1987;102:1055-61.
57. Marmon L, Au FC. The preoperative use of iodine solution in thyrotoxic patients prepared with propranolol. Is it necessary? Am Surg 1989;55:629-31.
58. Baeza A, Aguayo J, Barria M, Pineda G. Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol (Oxf) 1991;35:439-42.
59. Walter RM Jr, Bartle WR. Rectal administration of propylthiouracil in the treatment of Graves' disease. Am J Med 1990;88:69-70.